FdaApplication
ANDA 202150
Identifiers
- fda_app_no: ANDA202150
Properties
| Property | Value |
|---|---|
| applicant_name | HERITAGE PHARMACEUTICALS INC DBA AVET PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2014-03-07 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE | 12.5MG;7.5MG | TABLET;ORAL |
| MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE | 25MG;15MG | TABLET;ORAL |
| MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE | 12.5MG;15MG | TABLET;ORAL |
3 products